Ingar Morten K. Holme

Q: What Schools Are Affiliated With Ingar Morten K. Holme

Ingar Morten K. Holme is affiliated with the following schools: University of Oslo, Norwegian School of Sport Sciences

Ingar Morten K. Holme's AcademicInfluence.com Rankings

Mathematics

#5783

World Rank

#8110

Historical Rank

Statistics

#451

World Rank

#523

Historical Rank

Measure Theory

#938

World Rank

#1223

Historical Rank

mathematics Degrees

Download Badge

Mathematics

Why Is Ingar Morten K. Holme Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ingar Morten K. Holme's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Diabetes mellitus, fasting glucose, and risk of cause-specific death. (2011) (1874)
Effects of dalcetrapib in patients with a recent acute coronary syndrome. (2012) (1782)
High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. (2005) (1534)
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. (2008) (1473)
High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study (2001) (1223)
EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE Report from the Oslo Study Group of a Randomised Trial in Healthy Men (1981) (941)
Risk Factors for Injuries in Football (2004) (874)
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial (2003) (870)
Risk factors for sports injuries — a methodological approach (2003) (761)
Exercises to prevent lower limb injuries in youth sports: cluster randomised controlled trial (2005) (729)
Single blind, randomised controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment in management of genuine stress incontinence in women (1999) (662)
Comprehensive warm-up programme to prevent injuries in young female footballers: cluster randomised controlled trial (2008) (653)
The effect of warfarin on mortality and reinfarction after myocardial infarction. (1990) (645)
Long-term risks for kidney donors. (2014) (639)
Prevention of hamstring strains in elite soccer: an intervention study (2007) (575)
Comparison of self-reported versus accelerometer-measured physical activity. (2014) (544)
High apolipoprotein B, low apolipoprotein A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study☆ (2002) (542)
Physical fitness, injuries, and team performance in soccer. (2004) (513)
Benefit of a stroke unit: a randomized controlled trial. (1991) (501)
Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment (2008) (459)
Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: A prospective multicenter trial of the scandinavian glioblastoma study group (1981) (414)
Preventing injuries in female youth football – a cluster‐randomized controlled trial (2008) (405)
EFFECT OF PROPRANOLOL AND PRAZOSIN ON BLOOD LIPIDS The Oslo Study (1980) (393)
Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. (1997) (361)
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies. (2008) (357)
Intrinsic Risk Factors for Groin Injuries among Male Soccer Players (2010) (318)
Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction (2011) (314)
The natural course of acute sciatica with nerve root symptoms in a double-blind placebo-controlled trial evaluating the effect of piroxicam. (1993) (302)
Urban air pollution and mortality in a cohort of Norwegian men. (2004) (301)
Compliance with a comprehensive warm-up programme to prevent injuries in youth football (2010) (295)
Prevention of Injuries among Male Soccer Players (2008) (285)
The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk (2004) (277)
Helmet use and risk of head injuries in alpine skiers and snowboarders. (2006) (275)
An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence. (1990) (274)
Accelerometer-determined physical activity in adults and older people. (2012) (259)
Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS) (2009) (240)
Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study (2011) (229)
The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. (2007) (227)
Association of cardiac autonomic function and the development of hypertension: the ARIC study. (1996) (226)
Intrinsic Risk Factors for Hamstring Injuries Among Male Soccer Players (2010) (225)
Lung cancer and air pollution: a 27 year follow up of 16 209 Norwegian men (2003) (225)
Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. (2012) (220)
The Vertical Drop Jump Is a Poor Screening Test for ACL Injuries in Female Elite Soccer and Handball Players (2016) (211)
Lifestyle Changes May Reverse Development of the Insulin Resistance Syndrome. The Oslo Diet and Exercise Study: a randomized trial (1997) (210)
Relationship between floor type and risk of ACL injury in team handball (2003) (205)
Effect of long-term changes in diet and exercise on plasma leptin concentrations. (2001) (204)
Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia (2001) (198)
Reference values for cardiorespiratory response and fitness on the treadmill in a 20- to 85-year-old population. (2013) (197)
Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). (1999) (194)
Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. (2009) (187)
Effect of playing tactics on achieving score-box possessions in a random series of team possessions from Norwegian professional soccer matches (2010) (180)
The Oslo study. Cardiovascular disease in middle-aged and young Oslo men. (1975) (178)
Risk Factors of Stroke Incidence and Mortality: A 12‐Year Follow‐up of the Oslo Study (1993) (177)
Effect of playing tactics on goal scoring in Norwegian professional soccer (2010) (172)
Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. (2007) (162)
Risk Factors for Lower Extremity Injuries in Elite Female Soccer Players (2014) (162)
Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. (2006) (160)
Low Back Pain Among Endurance Athletes With and Without Specific Back Loading—A Cross-Sectional Survey of Cross-Country Skiers, Rowers, Orienteerers, and Nonathletic Controls (2004) (158)
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases (2007) (155)
Oslo Study Diet and Antismoking Trial. Results after 102 months. (1986) (152)
Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials. (1998) (148)
Combined diet and exercise intervention reverses the metabolic syndrome in middle‐aged males: results from the Oslo Diet and Exercise Study (2007) (145)
Risk Factors and Raised Atherosclerotic Lesions in Coronary and Cerebral Arteries (1981) (144)
High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study. (1978) (141)
High-intensity training following lung cancer surgery: a randomised controlled trial (2014) (137)
Ethnicity and sex are strong determinants of diabetes in an urban Western society: implications for prevention (2005) (135)
Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels. (2013) (134)
Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial. (2004) (133)
Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study (2010) (132)
Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial (2003) (130)
Effects of physical activity on schoolchildren's academic performance: The Active Smarter Kids (ASK) cluster-randomized controlled trial. (2016) (127)
Fluvastatin Prevents Cardiac Death and Myocardial Infarction in Renal Transplant Recipients: Post‐Hoc Subgroup Analyses of the ALERT Study (2004) (124)
A double‐blind, placebo‐controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome (2004) (123)
Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis. (2011) (116)
Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies (2018) (115)
Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial. (2001) (113)
Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease. (2009) (113)
Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives. (2005) (112)
Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease. (2012) (109)
Inflammation in renal transplantation. (2009) (107)
High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study. (1979) (104)
Four-year mortality by some socioeconomic indicators: the Oslo study. (1980) (103)
Diabetes susceptibility in ethnic minority groups from Turkey, Vietnam, Sri Lanka and Pakistan compared with Norwegians - the association with adiposity is strongest for ethnic minority women (2012) (101)
Errors that result from using the TC/HDL C ratio rather than the apoB/apoA‐I ratio to identify the lipoprotein‐related risk of vascular disease (2006) (97)
Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow‐up periods in the Apolipoprotein MOrtality RISk study (AMORIS) (2008) (97)
Rosuvastatin in diabetic hemodialysis patients. (2011) (97)
Dystonia and dyskinesia in glutaric aciduria type I: Clinical heterogeneity and therapeutic considerations (1994) (97)
Physical activity at work and at leisure in relation to coronary risk factors and social class. A 4-year mortality follow-up. The Oslo study. (2009) (96)
Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study. (1978) (95)
Increased Risk of All-Cause Mortality and Renal Graft Loss in Stable Renal Transplant Recipients With Hyperparathyroidism (2015) (93)
A prospective cohort study of depression in pregnancy, prevalence and risk factors in a multi-ethnic population (2015) (92)
Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES). (1995) (90)
Preventing eating disorders among young elite athletes: a randomized controlled trial. (2014) (90)
The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial. (2014) (88)
Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS) (2009) (87)
CORONARY RISK FACTORS AND SOCIOECONOMIC STATUS The Oslo Study (1976) (87)
Validity and reliability of bioelectrical impedance analysis and skinfold thickness in predicting body fat in military personnel. (2014) (86)
The effect of dietary changes on high density lipoprotein cholesterol. The Oslo Study. (1979) (85)
Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma. (1989) (84)
Intrinsic risk factors for acute ankle injuries among male soccer players: a prospective cohort study (2009) (84)
Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients. (2010) (82)
The Oslo Study: diet and antismoking advice. Additional results from a 5-year primary preventive trial in middle-aged men. (1985) (82)
Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) Report. (1995) (80)
Effects of Fluvastatin on Cardiac Events in Renal Transplant Patients: ALERT (Assessment of Lescol® in Renal Transplantation) Study Design and Baseline Data (2001) (80)
Self-Reported Injury History and Lower Limb Function as Risk Factors for Injuries in Female Youth Soccer (2008) (79)
Leisure time physical activity in middle age predicts the metabolic syndrome in old age: results of a 28-year follow-up of men in the Oslo study (2007) (79)
Risk factors for injuries in alpine skiing, telemark skiing and snowboarding – case-control study (2011) (78)
Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43 000 Swedish males and females (1992) (77)
Effects of a low glycemic load diet versus a low-fat diet in subjects with and without the metabolic syndrome. (2010) (75)
Antihypertensive Drugs and Blood Lipids: The Oslo Study (1982) (74)
Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic (2012) (74)
Treatment of Acute Low-back Pain with Piroxicam: Results of a Double-blind Placebo-controlled Trial (1987) (73)
Coronary risk factors in various occupational groups: the Oslo study. (1977) (72)
Validity of the ActiGraph GT1M during walking and cycling (2014) (70)
Promoting Physical Activity in a Low-Income Multiethnic District: Effects of a Community Intervention Study to Reduce Risk Factors for Type 2 Diabetes and Cardiovascular Disease (2006) (70)
Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction? (2006) (69)
Total cardiovascular disease burden: comparing intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial. (2009) (69)
The effect of an increased intake of vegetables and fruit on weight loss, blood pressure and antioxidant defense in subjects with sleep related breathing disorders (2007) (69)
Patterns of Objectively Measured Physical Activity in Normal Weight, Overweight, and Obese Individuals (20–85 Years): A Cross-Sectional Study (2013) (69)
Five-year mortality in the city of Bergen, Norway, according to age, sex and blood pressure. (2009) (68)
Improved carbohydrate metabolism after physical training and dietary intervention in individuals with the ‘atherothrombogenic syndrome’. Oslo Diet and Exercise Study (ODES). A randomized trial (1996) (68)
Treatment of mild hypertension with diuretics. The importance of ECG abnormalities in the Oslo Study and in MRFIT. (1984) (67)
Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial. (2010) (67)
Relation of coronary heart disease incidence and total mortality to plasma cholesterol reduction in randomised trials: use of meta-analysis. (1993) (65)
Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The Oslo study. (1984) (63)
Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial. (2011) (63)
An adapted version of the long International Physical Activity Questionnaire (IPAQ-L): construct validity in a low-income, multiethnic population study from Oslo, Norway (2007) (63)
Validity and reliability of the 20 meter shuttle run test in military personnel. (2011) (62)
Effects of a three-year intervention: the Copenhagen School Child Intervention Study. (2012) (62)
Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study). (2009) (62)
Cholesterol reduction and its impact on coronary artery disease and total mortality. (1995) (61)
The development of the brief eating disorder in athletes questionnaire. (2014) (59)
Rosuvastatin‐Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study (2015) (59)
A Cardiovascular Risk Calculator for Renal Transplant Recipients (2012) (59)
ApoB but not LDL‐cholesterol is reduced by exercise training in overweight healthy men. Results from the 1‐year randomized Oslo Diet and Exercise Study (2007) (59)
Nonfasting serum glucose and the risk of fatal stroke in diabetic and nondiabetic subjects. 18-year follow-up of the Oslo Study. (1995) (58)
Inflammation-associated graft loss in renal transplant recipients. (2011) (58)
Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). (2010) (58)
High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study. (1992) (58)
Exercise and diet interventions improve perceptions of self in middle‐aged adults (1997) (58)
A pilot study testing the feasibility of skin temperature monitoring to reduce recurrent foot ulcers in patients with diabetes – a randomized controlled trial (2015) (57)
Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population (2012) (56)
Serum triglycerides as an independent risk factor for death from coronary heart disease in middle-aged Norwegian men. (1989) (56)
Changes in physical activity behavior and the development of body mass index during the last 30 years in Norway (2008) (55)
Two short questionnaires on leisure-time physical activity compared with serum lipids, anthropometric measurements and aerobic power in a suburban population from Oslo, Norway (2007) (55)
Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study. (2009) (55)
Secular trends in adiposity in Norwegian 9-year-olds from 1999-2000 to 2005 (2009) (54)
Design and baseline characteristics of the Incremental Decrease in End Points through Aggressive Lipid Lowering study. (2004) (54)
Probucol treatment decreases serum concentrations of diet-derived antioxidants. (1995) (53)
Smoking habits and risk of fatal stroke: 18 years follow up of the Oslo Study. (1996) (53)
Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function. (2002) (53)
Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL) (2008) (53)
Markers of inflammation are inversely related to physical activity and fitness in sedentary men with treated hypertension. (2006) (53)
Possible metabolic side effects of beta-adrenergic blocking drugs. (1978) (53)
Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS) (2009) (51)
Four and two-thirds years incidence of coronary heart disease in middle-aged men: the Oslo study. (1980) (51)
The Oslo study: CHD risk factors, socioeconomic influences, and intervention. (1983) (49)
Effects of a 2‐year school‐based daily physical activity intervention on cardiovascular disease risk factors: the Sogndal school‐intervention study (2011) (49)
Association between the blood pressure response to a change in posture and the 6-year incidence of hypertension: prospective findings from the ARIC study (2002) (49)
Increases in physical activity is as important as smoking cessation for reduction in total mortality in elderly men: 12 years of follow-up of the Oslo II study (2015) (48)
Chlamydia pneumoniae Serology: Importance of Methodology in Patients with Coronary Heart Disease and Healthy Individuals (2001) (47)
Risk Factors for Coronary and Cerebral Atherosclerosis in the Oslo Study (1980) (44)
Stress reactivity to and recovery from a standardised exercise bout: a study of 31 runners practising relaxation techniques (2000) (44)
Increased fibrinolytic potential after diet intervention in healthy coronary high-risk individuals. (2009) (43)
The effect of acute vs chronic treatment with beta-adrenoceptor blockade on exercise performance, haemodynamic and metabolic parameters in healthy men and women. (1996) (42)
Socio-economic status as a coronary risk factor: the Oslo study. (2009) (42)
Cerebrovascular Events in Renal Transplant Recipients (2009) (42)
Intrinsic risk factors for acute knee injuries among male football players: a prospective cohort study (2011) (41)
The effect of exercise and diet on mental health and quality of life in middle-aged individuals with elevated risk factors for cardiovascular disease. (1999) (41)
The intercorrelation of serum cholesterol, cigarette smoking and body weight. The Oslo Study. (2009) (40)
The predictability of risk factors with respect to incidence and mortality of myocardial infarction and total mortality. A 12‐year follow‐up of the Oslo Study, Norway (1993) (39)
The External Validation of the Cardiovascular Risk Equation for Renal Transplant Recipients: Applications to BENEFIT and BENEFIT-EXT Trials (2013) (39)
Comparison of atorvastatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late (five years) after acute myocardial infarction (from the Incremental Decrease in End Points through Aggressive Lipid Lowering [IDEAL] trial). (2010) (39)
Determinants of Cardiovascular Risk in Haemodialysis Patients: Post hoc Analyses of the AURORA Study (2013) (39)
Coronary risk factors and their pathway of action through coronary raised lesions, coronary stenoses and coronary death. Multivariate statistical analysis of an autopsy series: the Oslo Study. (1985) (38)
6-year follow-up of 84 patients with cartilage defects in the knee (2010) (37)
Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study). (2010) (37)
Intervention Effects on Physical Activity and Insulin Levels in Men of Pakistani Origin Living in Oslo: A Randomised Controlled Trial (2012) (37)
Correlates of objectively measured physical activity in adults and older people: a cross-sectional study of population-based sample of adults and older people living in Norway (2014) (37)
Differences between echocardiographic measurements of left ventricular dimensions and function by local investigators and a core laboratory in a 2-year follow-up study of patients with an acute myocardial infarction. (2002) (36)
Ethnic Differences in Neonatal Body Composition in a Multi-Ethnic Population and the Impact of Parental Factors: A Population-Based Cohort Study (2013) (36)
The Prevalence of Low Back Pain Among Former Elite Cross-Country Skiers, Rowers, Orienteerers, and Nonathletes (2012) (36)
Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care. (1997) (36)
One‐ and five‐year follow‐ups on blood pressure and renal function in kidney donors (2011) (35)
The "Romsås in Motion" community intervention: program exposure and psychosocial mediated relationships to change in stages of change in physical activity (2007) (35)
The association between blood pressure and serum cholesterol in healthy men: the Oslo study. (1978) (35)
Promoting physical activity in a multi-ethnic district - methods and baseline results of a pseudo-experimental intervention study (2003) (34)
Objectively recorded physical activity and the association with gestational diabetes (2014) (33)
Stenoses in the coronary arteries. Relation to atherosclerotic lesions, coronary heart disease, and risk factors. The Oslo Study. (1985) (33)
A randomized, multicentre, double‐blind, parallel‐group study to assess the adverse event‐related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis (2009) (32)
Antihypertensive drugs and blood lipids: the Oslo study. (1982) (32)
The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis. (1996) (32)
Effects of doxazosin and atenolol on atherothrombogenic risk profile in hypertensive middle-aged men. (1998) (31)
The effect on HDL cholesterol of oxprenolol and atenolol. (1982) (31)
MAPHY and the two arms of HAPPHY. (1989) (30)
Risk factors associated with body mass index increase in men at 28 years follow-up. (2006) (30)
Associations between central obestiy and indexes of hemostatic, carbohydrate and lipid metabolism. Results of a 1‐year intervention from the Oslo Diet and Exercise Study (1998) (30)
Assessment of volar angulation and shortening in 5th metacarpal neck fractures: an inter- and intra-observer validity and reliability study (2013) (29)
A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis (2011) (29)
Exercise-induced increase in lipoprotein (a). (1996) (29)
Plant sterols from rapeseed and tall oils: effects on lipids, fat-soluble vitamins and plant sterol concentrations. (2010) (28)
Lipoprotein components and risk of congestive heart failure in 84 740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS) (2009) (27)
Effect of dietary and antismoking advice on the incidence of myocardial infarction: a 16-year follow-up of the Oslo Diet and Antismoking Study after its close. (2006) (27)
Monday and non‐Monday concentrations of lifestyle‐related blood components in the Oslo Diet and Exercise Study (1998) (27)
Helmet use and risk of head injuries in alpine skiers and snowboarders: changes after an interval of one decade (2016) (27)
Relation of age, the apolipoprotein B/apolipoprotein A-I ratio, and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease. (2007) (27)
High blood hemoglobin concentration as risk factor of major atherosclerotic cardiovascular events in 114,159 healthy men and women in the Apolipoprotein MOrtality RISk study (AMORIS) (2012) (26)
Effect of a low-fat versus a low-gycemic-load diet on inflammatory biomarker and adipokine concentrations. (2012) (25)
Psychosocial correlates of stages of change in physical activity in an adult community sample (2007) (24)
Comparative effect of atorvastatin (80 mg) versus simvastatin (20 to 40 mg) in preventing hospitalizations for heart failure in patients with previous myocardial infarction. (2009) (24)
Weight cycling and risk of forearm fractures: a 28-year follow-up of men in the Oslo Study. (2008) (24)
Serum insulin response to oral glucose load during a dietary intervention trial in healthy coronary high risk men: the Oslo study. (1980) (24)
Risk-factor profile for the incidence of subarachnoid and intracerebral haemorrhage, cerebral infarction, and unspecified stroke during 21 years' follow-up in men (2006) (23)
Effects of Match Location on Playing Tactics for Goal Scoring in Norwegian Professional Soccer (2010) (23)
Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial (2009) (23)
Prognostic model for total mortality in patients with haemodialysis from the Assessments of Survival and Cardiovascular Events (AURORA) study (2012) (22)
Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid‐lowering in primary care (1998) (21)
MRFIT and the Oslo study. (1983) (21)
The effect of kiwifruit consumption on blood pressure in subjects with moderately elevated blood pressure: A randomized, controlled study (2015) (21)
Piroxicam and naproxen plasma concentrations in patients with osteoarthritis: Relation to age, sex, efficacy and adverse events (1986) (21)
Maternal life course socio-economic position and offspring body composition at birth in a multi-ethnic population. (2014) (20)
Systemic inflammation in patients with inflammatory joint diseases does not influence statin dose needed to obtain LDL cholesterol goal in cardiovascular prevention (2014) (20)
Lifelong benefits on myocardial infarction mortality: 40‐year follow‐up of the randomized Oslo diet and antismoking study (2016) (20)
Adjusting parameters of aortic valve stenosis severity by body size (2014) (19)
Effect of greater LDL-C reductions on prognosis-the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial (1999) (19)
Adherence-adjusted efficacy with intensive versus standard statin therapy in patients with acute myocardial infarction in the IDEAL study (2009) (19)
Dianicline, a novel α4β2 nicotinic acetylcholine receptor partial agonist, for smoking cessation: a randomized placebo-controlled clinical trial. (2011) (18)
Quantitation of atherosclerosis in femoral arteriography with ECG gated exposures. (1988) (18)
The relation of coronary and peripheral arterial disease to the severity of femoral atherosclerosis in hypercholesterolaemia (1994) (17)
The “Romsås in Motion” Community Intervention: Mediating Effects of Psychosocial Factors on Forward Transition in the Stages of Change in Physical Activity (2009) (16)
Seasonal variations of pigmented naevi. Intercorrelations of clinical and histological variables with special reference to seasonal variation. (1990) (16)
A 24-week multicenter double-blind study of doxazosin and hydrochlorothiazide in patients with mild to moderate essential hypertension. (2009) (16)
Association between Risk Factors and Atherosclerotic Lesions Based on Autopsy Findings in the Oslo Study: A Preliminary Report (1977) (16)
Associations between type A behaviour pattern and psychological distress (2008) (16)
DHA reduces oxidative stress following hypoxia-ischemia in newborn piglets: a study of lipid peroxidation products in urine and plasma (2018) (16)
[Coronary risk factors and socioeconomic status. The Oslo study]. (1977) (16)
The Effect of Anesthesia on Intraoperative and Postoperative Bleeding during Abdominal Prostatectomies: A Comparison of Neurolept Anesthesia, Halothane Anesthesia and Epidural Anesthesia (1975) (15)
Arterial and venous plasma catecholamines during submaximal steady-state exercise. (1998) (15)
[Physical activity, smoking and mortality among men who participated in the Oslo studies of 1972 and 2000]. (2014) (15)
Effect of cimetidine on gastrointestinal symptoms in patients taking nonsteroidal anti-inflammatory drugs. A large double-blind placebo controlled study. (1994) (15)
A double-blind multicentre trial of piroxicam and naproxen in osteoarthritis (2005) (15)
CORONARY RISK FACTORS AND SOCIOECONOMIC STATUS (1977) (14)
Effect of lifestyle and/or statin treatment on soluble markers of atherosclerosis in hypertensives (2007) (14)
Cholesterol Reduction and Total Mortality (1991) (13)
Relationship between total mortality and cholesterol reduction as found by meta-regression analysis of randomized cholesterol-lowering trials. (1996) (13)
Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipients. (2013) (13)
Co-variation of alanine aminotransferase levels with relative weight in blood donors. (1992) (13)
Risk of fatal stroke according to blood pressure level: an 18-year follow-up of the Oslo Study (1995) (13)
Quality-adjusted meta-analysis of the hypertension/coronary dilemma. (1994) (13)
On the separation of the intervention effects of diet and antismoking advice on the incidence of major coronary events in coronary high risk men. The Oslo Study. (1982) (13)
Trends in the incidence of acute myocardial infarction and stroke: a 21‐year follow‐up of the Oslo study (2004) (12)
Selective alpha 1 inhibition with doxazosin in hypertensive smokers and non-smokers: haemodynamic and metabolic effects. (1990) (12)
Association of coronary heart disease mortality with risk factors according to length of follow-up and serum cholesterol level in men: the Oslo Study cohort (2013) (12)
Cartilage repair in the rabbit knee: mosaic plasty resulted in higher degree of tissue filling but affected subchondral bone more than microfracture technique (2012) (12)
Correlates of systolic and diastolic blood pressure in men 40 to 59 years of age sampled from United States of America and Union of Soviet Socialist Republics Lipid Research Clinics populations. (1988) (12)
Level of physical activity, cardiorespiratory fitness and cardiovascular disease risk factors in a rural adult population in Sogn og Fjordane (2011) (11)
Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting (2015) (11)
Tegaserod is an effective and safe therapy for irritable bowel syndrome in a nordic population (2003) (11)
Combined modality treatment of operated astrocytomas grade 3–4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy (1984) (11)
Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients (2013) (11)
Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL). (2009) (11)
LDL cholesterol goals and cardiovascular risk during statin treatment: the IDEAL study (2011) (11)
Symmetric Dimethylarginine as Predictor of Graft loss and All-Cause Mortality in Renal Transplant Recipients (2014) (11)
The built environment correlates of objectively measured physical activity in Norwegian adults: A cross-sectional study (2017) (10)
Predictiveness of body mass index for fatal coronary heart disease in men according to length of follow-up: A 21-year prospective cohort study (2007) (10)
HDL-cholesterol in antihypertensive treatment. The Oslo Study. (2009) (10)
Anthropometrics, Body Composition, And Aerobic Fitness in Norwegian Home Guard Personnel (2014) (10)
A randomized study on hormone-resistant prostatic cancer: estramustine phosphate versus low dose epirubicin with or without medroxyprogesterone acetate. A Norwegian multicenter study. (1990) (10)
Coronary risk factors and their possible causal role in the development of coronary heart disease: the Oslo study. (1982) (10)
Effects of lipid-lowering therapy on total and coronary mortality. (1995) (9)
Correlates of blood pressure change in middle-aged male mild hypertensives: results from the untreated control group in the Oslo hypertension trial. The Oslo Study. (1988) (9)
The Vertical Drop Jump Is a Poor Screening Test for ACL Injuries: Response (2016) (9)
Physical activity and cardiovascular risk factors in a 40- to 42-year-old rural Norwegian population from 1975–2010: repeated cross-sectional surveys (2014) (9)
[Changes in cardiovascular risk factors among men in Oslo during 28 years]. (2006) (9)
Exposure therapy and sertraline in social phobia: Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial 1-year follow-up of a randomised controlled trial (2003) (9)
Drug treatment of mild hypertension to reduce the risk of CHD: is it worth-while? (1988) (9)
[Risk factors and mortality--a follow-up of the Oslo Health Study from 1972-73]. (2011) (9)
Influence of lipoprotein lipids, dietary fat and smoking on macrophage degradation of native and oxidized low density lipoprotein. (1994) (9)
Rosuvastatin induced carotid plaque regression in patients with inflammatory joint diseases (2014) (9)
Prediction of Cardiovascular Events in Patients with Ankylosing Spondylitis and Psoriatic Arthritis: Role of Lipoproteins in a High-risk Population (2012) (9)
Objectively Measured Physical Activity in Home Guard Soldiers During Military Service and Civilian Life. (2016) (8)
Incidence of hypertrophic cardiomyopathy in hypothyroidism. (1995) (8)
Preliminary results of the Norwegian doxazosin postmarketing surveillance study: a twelve-week experience. (1991) (8)
RISK FACTORS FOR LOWER EXTREMITY INJURIES IN ELITE FEMALE FOOTBALL PLAYERS (2014) (7)
Comparison of predictive ability of lipoprotein components to that of traditional risk factors of coronary events in renal transplant recipients. (2010) (7)
Survival in elderly men in relation to midlife and current BMI. (2015) (6)
The effect of anesthesia on intraoperative and postoperative bleeding during abdominal prostatectomies: a comparison of neurolept anesthesia, halothane anesthesia and epidural anesthesia. (1976) (6)
Cholesterol lowering and the reduction of CHD incidence and total mortality: Results from a meta-analysis of randomized trials (1992) (6)
Long-Term Correlates of Objectively Measured Physical Activity and Sedentary Time in Norwegian Men and Women. (2015) (6)
On‐treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets study (2011) (6)
Apolipoproteins and prediction of fatal myocardial infarction (2002) (6)
Relation of number of different responses to group size and stimulus words in a discrete free‐association situation (1973) (5)
Piroxicam and naproxen in patients with osteoarthritis of the hip waiting for total hip replacement (1988) (5)
Tu-W20:4 Apolipoprotein B/A1 ratio is a better discriminator of risk of coronary heart disease than is LDL/HDL cholesterol ratio in the ideal study (2006) (5)
Uric acid and clinical correlates of endothelial function in kidney transplant recipients (2014) (5)
Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study (2012) (5)
Increased Predictive Ability of BMI but not Other Risk Factors with Time in Men: 39-Year Follow-Up of Total Mortality in the Oslo Study (2014) (5)
[Predictors for 21-year incidence of myocardial infarction in the Oslo study 1972/73]. (2003) (4)
Survival of AIDS Patients in Norway (1990) (4)
Risk factors for unexpected sudden death in patients with non-symptomatic aortic stenosis (the SEAS study) (2010) (4)
[The Oslo study. 4-year mortality, coronary risk factors and socioeonomic indicators]. (1980) (4)
High apolipoprotein (apo) B and low apoA-i improve the prediction of fata myocardial infarction at all levels of cholesterol and triglycerides — mortality data from the amoris (apolipoprotein-related mortality risk) study (2000) (4)
Outcome in 1763 asymptomatic patients with mild or moderate calcific aortic stenosis followed prospectively with annual echocardiography (2013) (4)
Repeated Weight Loss is Associated with the Metabolic Syndrome and Diabetes: Results of a 28 Year Re-screening of Men in the Oslo Study. (2007) (4)
[Drug therapy in mild hypertension. A review of randomized trials]. (1988) (3)
[Echocardiographic findings, pro-ANP and treatment in acute myocardial infarction without overt heart failure]. (1999) (3)
Extension of clinical trials. 10 1/2 year follow-up of the Multiple Risk Factor Intervention Trial. (1990) (3)
trialsports: cluster randomised controlled Exercises to prevent lower limb injuries in (2005) (3)
Long-term survival in pre-specified groups at risk in the Oslo Study, 1972–1973 (2015) (3)
Abstract 3357: Superiority of ApoB/ApoA1 Ratio for Predicting Cardiovascular Risk in Pooled Analyses of the Incremental Decrease in Endpoints through Aggressive Lipid-Lowering (IDEAL) and Treating to New Targets (TNT) Trials (2006) (3)
Repeated measurements over time: statistical analysis of the angiographic outcomes in the Probucol Quantitative Regression Swedish Trial (PQRST). (1993) (3)
[Mortality of Norwegian physicians in the period 1953-72 in relation to their smoking habits in 1952-3]. (1976) (2)
Cholesterol reduction in single and multifactor randomized trials: relationship to CHD incidence and total mortality as found by meta analysis of twenty-two trials. (1992) (2)
The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease—a cross sectional study: Respir Med 2006; published online ahead of print on 3 may 2006 as doi:10.1016/j.rmed.2006.03.029 (2006) (2)
Effects of fluvastatin on cardiac events in renal transplant recipients (2001) (2)
Blood lipids and antihypertensive drugs. The Oslo study. (1983) (2)
Prevention of Knee and Ankle Injuries in Youth Team Handball - A Randomized Control Trial (2004) (2)
Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with baseline elevations in alanine aminotransferase levels (2013) (2)
Reproducibility of Quantitative Arteriographic Assessment of Atherosclerosis in the Femoral Artery (1993) (2)
Mental "stress" and coronary risk factors. The Oslo study. (1977) (2)
programme to prevent injuries in youth football Compliance with a comprehensive warm-up (2010) (2)
Lowering of HDL-2b partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hyupercholesterolemia. A Probucol Quantitative Regression Swedish Trail (PQRST) report. (1995) (2)
Re: Risk of End-Stage Renal Disease Following Live Kidney Donation (2014) (2)
[Treatment with statins of the elderly]. (2004) (2)
[Is a healthy lifestyle worthwhile?]. (2006) (2)
[Piroxicam and naproxen in arthrosis. A double-blind, comparative multicenter study in general practice]. (1986) (2)
Smoking and Atherosclerotic Disease. The Oslo Study (1983) (1)
Long-term survival in the randomized trial of drug treatment in mild to moderate hypertension of the Oslo study 1972-3. (2015) (1)
The evaluation of possible melanoma risk groups of patients in a series of pigmented naevi. Clinical and histological intercorrelations. (1988) (1)
Response to Letters Regarding Article, “Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction” (2011) (1)
PROGNOSTIC MODEL OF RESIDUAL RISK FOR MAJOR CARDIOVASCULAR EVENTS IN STATIN-TREATED CORONARY PATIENTS: A COMBINED ANALYSIS OF THE IDEAL AND TNT TRIALS (2012) (1)
[Treatment with statins: further data from the Heart Protection Study]. (2002) (1)
Apolipoproteins and prediction of fatal myocardial infarction. Authors' reply (2002) (1)
[The effect of doxazosin on blood pressure, lipids, fibrinogen and plasminogen activator inhibitor. A comparative study among smokers and non-smokers with essential hypertension]. (1991) (1)
[Cardiovascular risk factors among 40-year old men and women in Oslo 1981-1999]. (2004) (1)
206: A Comparison of the Association of On-Treatment Lipid and Apolipoprotein Parameters to Cardiovascular Events in IDEAL and TNT (2007) (1)
CHOLESTEROL, SMOKING, AND THE OSLO STUDY (1982) (1)
Long-term mortality after primary prevention for cardiovascular disease. (1992) (1)
RENAL TRANSPLANT FUNCTION AS A RISK FACTOR FOR CARDIOVASCULAR DISEASE AND MORTALITY AND FOR ALL CAUSE MORTALITY IN RENAL TRANSPLANTATION - EXPERIENCE FROM THE ALERT TRIAL (2004) (1)
Screening Tests for ACL Injury: Response (2016) (1)
[Cholesterol lowering therapy after myocardial infarction. Consequences of the CARE study]. (1997) (1)
[Doxazosin (Carduran)--a research survey]. (1993) (1)
Th-W55:5 The effect of an increased intake of vegetables and fruit on weight, blood pressure and antioxidant defense in subjects with sleep apnea disorders (2006) (1)
Can frozen and thawed blood samples stored for 12-14 years be used to measure levels of apolipoproteins? Analysis from HUNT 2 data. (2010) (1)
LB-OR-2 HIGH HDL-C AND CHD RISK IN STATIN-TREATED CHD PATIENTS: ANALYSIS OF INCREMENTAL DECREASE IN ENDPOINTS THROUGH AGGRESSIVE LIPID-LOWERING (IDEAL) TRIAL (2007) (0)
[Beta blockaders do not influence the development of arteriosclerosis]. (1989) (0)
Hyperparathyroidism in Stable Renal Transplant Recipients Is Associated With All-Cause Mortality and Renal Graft Loss (2014) (0)
Effects of Intensive Lipid Lowering With Atorvastatin on Peripheral Arterial Disease in Patients With Coronary Heart Disease (2010) (0)
M.443 Fluvastatin slows progression of atherosclerosis and left ventricular hypertrophy in dyslipidemic hypertensive men: The hypertension high risk management trial (HYRIM) (2004) (0)
Reference values for cardiorespiratory fitness in a 20 - 85 year old population (2012) (0)
1.P.380 Hypertension high risk management trial (HYRIM): Prevention of atherosclerosis and left ventricular hypertrophy development by intensive life-style or fluvastatin treatment in hypertensives (1997) (0)
Mortality among patients who survived their first myocardial infarction. (1976) (0)
Clinical and histological intercorrelations in pigmented naevi indicating potential melanoma precursor lesions (1988) (0)
[Physically active and inactive groups: the Oslo Study] (1983) (0)
CLINICAL/ORIGINAL PAPERS Differences Between Echocardiographic Measurements of Left Ventricular Dimensions and Function by Local Investigators and a Core Laboratory in a 2-year Follow-up Study of Patients with an Acute Myocardial Infarction (2002) (0)
Diuretics and Coronary Heart Disease-Reply (1985) (0)
Cholesterol Reduction and Total Mortality Recently in Circulation (2005) (0)
RELATIONSHIP BETWEEN BASELINE LIPOPROTEIN PARAMETERS AND CHRONIC KIDNEY DISEASE IN CORONARY PATIENTS (2013) (0)
and trial youth sports : cluster randomised controlled Exercises to prevent lower limb injuries in (2005) (0)
Effect of long-term changes in diet and exercise on plasma leptin concentrations 1 – 3 (0)
788 EFFECT OF INTENSIVE LIPID LOWERING ON CARDIOVASCULAR OUTCOME IN PATIENTS WITH AND WITHOUT INFLAMMATORY JOINT DISEASE (2011) (0)
101/2 Year Follow-up of the Multiple Risk Factor Intervention Trial (2005) (0)
Femoral Lesion Change in Relation to Measured Risk Factors in the Stockholm-Uppsala Trial (1990) (0)
[Diagnosis of high risk of heart disease among asymptomatic persons]. (2002) (0)
Inﬂammation-associated graft loss in renal transplant recipients (2011) (0)
Tu-W29:7 Effect of differential treatment adherence on outcome in the ideal trial (2006) (0)
Exercise induced increase in lipoprotein(a). Results from the Oslo diet and exercise study (ODES) (1995) (0)
IMPORTANCE OF TRIGLYCERIDES IN PATIENTS AT LDL-C GOAL: ANALYSIS OF INCREMENTAL DECREASE IN ENDPONTS THROUGH AGGRESSIVE LIPID LOWERING (IDEAL) TRIAL (2008) (0)
Impact of Severity of Aortic Valve Stenosis on Effect of Intensive Lipid-Lowering Therapy: The SEAS Study (2009) (0)
The Population In Sogn og Fjordane, Norway - Fittest There Is?: 2627 (2011) (0)
Abstract: 28 CONSISTENCY BETWEEN LIPID LOWERING AND REDUCTION OF ISCHEMIC CARDIOVASCULAR EVENTS (ICE) IN THE SIMVASTATIN AND EZETIMIBE IN AORTIC STENOSIS (SEAS) TRIAL (2009) (0)
PHYSICAL ACTIVITY, CARDIORESPIRATORY FITNESS AND INTIMA-MEDIA THICKNESS IN HYPERTENSIVE PATIENTS (2003) (0)
PO23-735 RISK REDUCTION WITH INTENSIVE VERSUS STANDARD STATIN THERAPY IN ACUTE CORONARY SYNDROME: IDEAL TRIAL (2007) (0)
LDL CHOLESTEROL GOAL ATTAINMENTS IN THE IDEAL STUDY (2008) (0)
Effect of Lifestyle Intervention Emphasizing Physical Activity on Risk Factors for Diabetes and Cardiovascular Disease among High-risk Individuals: 710 (2007) (0)
EFFECT OF DIFFERENTIAL TREATMENT ADHERENCE IN RECENT MI PATIENTS IN THE IDEAL TRIAL (2008) (0)
PO23-737 A COMPARISON OF THE ASSOCIATION OF ON-TREATMENT LIPID AND APOLIPOPROTEIN PARAMETERS TO CARDIOVASCULAR EVENTS IN IDEAL AND TNT (2007) (0)
Outcome of Asymptomatic Patients With Low Gradient "Severe" Aortic Valve Stenosis and Preserved Ejection Fraction - Results From the Prospective SEAS Study (2009) (0)
Abstract 16175: Effect of Dietary Intake of Kiwi Fruit on 24-Hour Ambulatory Blood Pressure (2011) (0)
Treatment of Borderline and Mild Hypertension: The Oslo Study (1981) (0)
Comparing Cardiorespiratory Fitness Across Populations: Response (2014) (0)
O212 Predictive Value of Lipoprotein Parameters on the Risk of Chronic Kidney Disease in Patients with Coronary Heart Disease (2014) (0)
CHOLESTEROL REDUCTION AND TOTAL MORTALITY. AUTHOR'S REPLY (1991) (0)
1 .P 377 Evaluation of the angiotensinogen locus in human essential lipidic composition of de patients with arterial hypertension and without hypertension: An European study obesity. (1997) (0)
High-dose statins and the IDEAL study. Authors' reply (2006) (0)
Abstract 2455: Intensive Statin Therapy Reduces Risk of Cardiovascular Disease Beyond Occurrence of the First Event: Analysis of the Incremental Decrease in Endpoints through Aggressive Lipid Lowering Trial (2007) (0)
MS328 EFFECTS OF INTENSIVE LIPID LOWERING WITH ATORVASTATIN ON PERIPHERAL ARTERIAL DISEASE IN PATIENTS WITH CORONARY HEART DISEASE (2010) (0)
RiskFactors ofStroke Incidence andMortalit A 12-Year Follow-up oftheOsloStudy (2011) (0)
WARFARIN AFTER MYOCARDIAL INFARCTION. AUTHOR'S REPLY (1990) (0)
Effects Of A Two-year School-based Daily Physical Activity Intervention On Cvd Risk Factors: 1371 (2011) (0)
Comment on Schiøtz et al.: Ten-year follow-up after conservative treatment of stress urinary incontinence (2009) (0)
EFFECTS OF DIET AND EXERCISE UPON LIPOPROTEIN SUBFRACTIONS - THE OSLO DIET AND EXERCISE STUDY 521 (1997) (0)
Probucol displaces carotenoids from LDL (1994) (0)
Abstract 16388: Efficacy and Safety of Early Dalcetrapib Treatment on Lipid Profile and Markers of HDL Functionality in Patients Hospitalized for an Acute Coronary Syndrome - The dal-ACUTE Study (2012) (0)
Relations between serum lipoproteins and soluble markers of endothelial function in men on antihypertensive drugs (2001) (0)
785 PREDICTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS (2011) (0)
4.P.126 Effect of long term changes in diet and exercise on plasma leptin levels: Correlation to nutrients, homeostatic variables and coronary risk factors (1997) (0)
Reproductive toxicology. Ethoxyacetic acid. (1997) (0)
[Do beta-blockers protect against myocardial infarction?]. (1988) (0)
PO23-741 ON-TREATMENT HDL-C LEVELS AND RISK OF MAJOR CARDIOVASCULAR EVENTS IN THE IDEAL TRIAL (2007) (0)
INTENSIVE ATORVASTATIN THERAPY REDUCES RISK OF CARDIOVASCULAR EVENTS BEYOND THE FIRST EVENT IN PATIENTS WITH MULTIPLE EVENTS (2008) (0)
Valvular Heart Disease Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction (2011) (0)
PO23-743 EFFECT OF INTENSIVE VERSUS STANDARD STATIN THERAPY IN YOUNGER AND OLDER CORONARY HEART DISEASE (CHD) PATIENTS IN THE IDEAL TRIAL (2007) (0)
[Non-medical treatment of coronary high risks]. (2000) (0)
1116-33 Renal transplant function as a risk factor for cardiovascular events and for all cause mortality in a renal transplant population: Experience from the ALERT trial (2004) (0)
Development of coronary risk factors in young Oslo males. A comparison between a survey in 40 year old men and the Oslo Study in 1972/73. (1987) (0)
LB-PO-858 APOB/APOA-1 IS MORE PREDICTIVE OF AMI IN RHEUMATOID ARTHRITIS THAN LDL-C OR NHDL-C/HDL-C IN THE AMORIS STUDY (2007) (0)
approachfactors for sports injuries — a methodological (2005) (0)
[Apolipoproteins are better risk markers than conventional lipids]. (2007) (0)
1124-191 Predictive risk factors for coronary events in renal transplant patients (2004) (0)
Abstract: P824 CAN LIPID/APOLIPOPROTEIN FACTORS ACCOUNT FOR RESIDUAL RISK IN PATIENTS ATTAINING CURRENT LDL-C TARGETS? (2009) (0)
Knee scores improved but recovery was incomplete (2010) (0)
Quantitation of Atherosclerosis in Femoral Arteriography with Ecg Gated Exposures (1988) (0)
Which plasma lipoproteins contributes to the development of intermittent claudication? A multivariate regression analysis of randomly selected subjects (1992) (0)
Validation of the ALERT Risk Prediction Equations in the Patient Outcomes in Renal Transplantation (PORT) Study: 721 (2012) (0)
Prenatal stress : effects on energy homeostasis and cognitive performance (2009) (0)
[Statin therapy of individuals with high risk for coronary disease]. (1996) (0)
years follow up of the Oslo Study . Smoking habits and risk of fatal stroke : 18 (0)
[Antihypertensive agents and blood lipids--The Oslo study]. (1982) (0)
P178 CORONARY PATIENTS REACHING LDL-CHOLESTEROL < 2.0 mmol/L HAVE THE LOWEST RISK OF CARDIOVASCULAR EVENTS DURING STATIN TREATMENT: THE IDEAL STUDY (2010) (0)
High-dose statins and the IDEAL study : Reply (2006) (0)
Probucol and the PQRST — a look back and a look ahead (1994) (0)
PO23-736 EFFECT OF ADHERENCE DIFFERENCES TO ATORVASTATIN 80 MG (A80) VERSUS SIMVASTATIN 20-40 MG (S20-40) IN CORONARY HEART DISEASE (CHD) PATIENTS (2007) (0)
LB-OR-3 RELATIONSHIP BETWEEN HIGH-DENSITY LIPOPROTEIN PARTICLE SIZE AND CORONARY ARTERY DISEASE RISK IN THE EPIC-NORFOLK PROSPECTIVE STUDY (2007) (0)
LB-PO-859 LIPID LEVELS AS PREDICTORS OF DEVELOPMENT OF RHEUMATOID ARTHRITIS IN THE AMORIS POPULATION (2007) (0)
Coronary risk and socio-economic status, the Oslo study. (2009) (0)
STATINS AND RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY REVASCULARIZATION (CR) IN THE IDEAL TRIAL (2008) (0)
[Should we perform long-term cohort studies on the use of antihypertensive agents?]. (1990) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ingar Morten K. Holme?

Ingar Morten K. Holme is affiliated with the following schools:

Ingar Morten K. Holme's Academic­Influence.com Rankings

Why Is Ingar Morten K. Holme Influential?

Ingar Morten K. Holme's Published Works

Published Works

What Schools Are Affiliated With Ingar Morten K. Holme?

Ingar Morten K. Holme's AcademicInfluence.com Rankings